CELERITY 20 HP Challenge Pack

K220473 · Steris · FRC · Mar 18, 2022 · General Hospital

Device Facts

• Record ID: K220473
• Device Name: CELERITY 20 HP Challenge Pack
• Applicant: Steris
• Product Code: FRC · General Hospital
• Decision Date: Mar 18, 2022
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 880.2800
• Device Class: Class 2

Intended Use

The CELERITY 20 HP Challenge Pack is intended for qualification testing of the V-PRO Low Temperature Sterilization System following installation, relocation, malfunctions or major repairs and for routine requalification testing. The Challenge Pack is placed in an otherwise empty sterilizer chamber; a hospital-defined chad is not included. The challenge pack is not intended for routine monitoring of the V-PRO Sterilizers. It has been tested and validated solely for use in periodic testing of the sterilizers.

Device Story

Challenge pack contains biological indicator (BI), chemical indicator (CI), and barrier material in sealed pouch; used for qualification testing of V-PRO Low Temperature Sterilization Systems. Healthcare provider places pack in empty sterilizer chamber; performs sterilization cycle. Post-cycle, user retrieves CI and BI; CI checked for color change; BI activated by sealing vial to release media. Activated BI incubated at 55-60°C in CELERITY HP Incubator; viability determined within 20 minutes. Output confirms sterilization efficacy; informs clinical decision-making regarding sterilizer readiness for use. Benefits patient by ensuring sterilization equipment functions correctly before clinical deployment.

Clinical Evidence

Bench testing only. Simulated use testing performed in V-PRO maX 2 Sterilizer (Fast Non Lumen Cycle) demonstrated passing results: all chemical indicators showed complete change and all biological indicators were inactivated.

Technological Characteristics

Sealed sterilization pouch containing Celerity 20 HP Biological Indicator, VERIFY HPU Chemical Indicator, and barrier material. Requires CELERITY HP Incubator (55-60°C) for BI processing. Standalone device; no software or connectivity.

Indications for Use

Indicated for qualification and routine requalification testing of V-PRO Low Temperature Sterilization Systems following installation, relocation, malfunction, or major repair. Not for routine monitoring.

Regulatory Classification

Identification

Biological sterilization process indicator: A device intended for use by a health care provider to accompany products being sterilized through a sterilization procedure and to monitor adequacy of sterilization. The device consists of a known number of microorganisms, of known resistance to the mode of sterilization, in or on a carrier and enclosed in a protective package. Subsequent growth or failure of the microorganisms to grow under suitable conditions indicates the adequacy of sterilization. Physical/chemical sterilization process indicator: A device intended for use by a health care provider to accompany products being sterilized through a sterilization procedure and to monitor one or more parameters of the sterilization process. The adequacy of the sterilization conditions as measured by these parameters is indicated by a visible change in the device.

Predicate Devices

• CELERITY 20 HP Challenge Pack (K173488)

Reference Devices

• CELERITY 20 HP Challenge Pack (K183294)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which consists of the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in blue, and the word "ADMINISTRATION" in a smaller font below that.

March 18, 2022

Steris Anthony Piotrkowski Director, Regulatory Affairs 5960 Heisley Rd. Mentor, Ohio 44060

Re: K220473

Trade/Device Name: CELERITY 20 HP Challenge Pack Regulation Number: 21 CFR 880.2800 Regulation Name: Sterilization Process Indicator Regulatory Class: Class II Product Code: FRC Dated: February 17, 2022 Received: February 18, 2022

Dear Anthony Piotrkowski:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part

{1}------------------------------------------------

801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4. Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

Clarence W. Murray, III, Ph.D. Assistant Director DHT4B: Division of Infection Control and Plastic Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

# Indications for Use

### 510(k) Number (if known) K220473

### Device Name

CELERITY 20 HP Challenge Pack

### Indications for Use (Describe)

The CELERITY 20 HP Challenge Pack is intended for qualification testing of the V-PRO Low Temperature Sterilization System following installation, relocation, malfunctions or major repairs and for routine requalification testing.

The Challenge Pack is placed in an otherwise empty sterilizer chamber; a hospital-defined chad is not included.

The challenge pack is not intended for routine monitoring of the V-PRO Sterilizers. It has been tested and validated solely for use in periodic testing of the sterilizers.

| Type of Use (Select one or both, as applicable) | |
|------------------------------------------------------------|-----------------------------------------------------------|
| <span></span> Prescription Use (Part 21 CFR 801 Subpart D) | <span></span> Over-The-Counter Use (21 CFR 801 Subpart C) |

### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

# K220473 510(k) Summary For CELERITY 20 HP Challenge Pack

# Sponsor Facility

STERIS Corporation 5960 Heisley Road Mentor, OH 44060 Phone: [phone] Fax No: [phone]

# Manufacturing Facility

STERIS Corporation 9325 Pinecone Drive Mentor, OH 44060 Phone: [phone] Fax No: [phone]

Contact: Anthony Piotrkowski Director, Regulatory Affairs

Telephone: [phone] [phone] Fax No: e-mail: tony [e-mail]

February 17, 2022 Submission Date:

STERIS Corporation ■ 5960 Heisley Road ■ Mentor, OH 44060-1834 USA ■ 440-354-2600

{4}------------------------------------------------

# STERIS SPECIAL 510(k) PREMARKET NOTIFICATION CELERITY 20 HP Challenge Pack

#### Device Name 1.

| Trade Name: | CELERITY 20 HP Challenge Pack |
|------------------------|-----------------------------------------------------------------------|
| Common/usual Name: | Biological Indicator Challenge Pack |
| Device Classification: | Class II |
| Classification Name: | Indicator, Biological Sterilization Process<br>(21 CFR 880.2800, FRC) |

### 2. Predicate Device

CELERITY 20 HP Challenge Pack K173488 Note: K183294 is the most recent clearance for the CELERITY 20 HP Challenge pack but this submission specifically addresses the original clearance under K173488.

### 3. Description of Device

The CELERITY 20 HP Challenge Pack (pack), is used by healthcare providers for qualification testing of the V-PRO Low Temperature Sterilization Systems. The pack is placed in an otherwise empty sterilizer chamber; a hospital-defined challenge load is not included.

The user places the pack into the V-PRO Sterilizer and performs a sterilization cycle. After cycle completion, the VERIFY HPU Chemical Indicator (CI) and the CELERITY 20 HP Biological Indicator (BI) contained in the pack are retrieved. The CI is assessed for a passing color change immediately and the BI can either be immediately activated or it can be held at room temperature for a maximum of 72 hours (3 days) prior to activation.

The BI is activated by sealing the vial and thus puncturing the cap to release the contained media. The activated SCBI is incubated at 55-60 ℃ in the CELERITY HP Incubator for a final determination of viability within 20 minutes of incubation.

#### 4. Intended Use/ Indications for Use

The CELERITY 20 HP Challenge Pack is intended for qualification testing of the V-PRO Low Temperature Sterilization System following installation, relocation, malfunctions or major repairs and for routine requalification testing.

The Challenge Pack is placed in an otherwise empty sterilizer chamber; a hospitaldefined challenge load is not included.

The challenge pack is not intended for routine monitoring of the V-PRO Sterilizers. It has been tested and validated solely for use in periodic testing of the sterilizers.

{5}------------------------------------------------

#### 5. Summary of Technological Characteristics

A comparison of technical characteristics are summarized in Table 5-1.

| Feature | CELERITY pack<br>(proposed) | CELERITY Pack<br>(K173488) Predicate | Comparison |
|---------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|
| Intended Use /<br>Indication for Use | The CELERITY 20 HP Challenge<br>Pack is intended for qualification<br>testing of the V-PRO Low<br>Temperature Sterilization System<br>following installation, relocation,<br>malfunctions or major repairs and for<br>routine requalification testing.<br><br>The Challenge Pack is placed in an<br>otherwise empty sterilizer chamber; a<br>hospital-defined challenge load is not<br>included.<br><br>The challenge pack is not intended for<br>routine monitoring of the V-PRO<br>Sterilizers. It has been tested and<br>validated solely for use in periodic<br>testing of the sterilizers. | The CELERITY 20 HP Challenge<br>Pack is intended for qualification<br>testing of the V-PRO Low<br>Temperature Sterilization System<br>following installation, relocation,<br>malfunctions or major repairs and for<br>routine requalification testing.<br><br>The Challenge Pack is placed in an<br>otherwise empty sterilizer chamber; a<br>hospital-defined challenge load is not<br>included.<br><br>The challenge pack is not intended for<br>routine monitoring of the V-PRO<br>Sterilizers. It has been tested and<br>validated solely for use in periodic<br>testing of the sterilizers. | Same |
| General Design | Sealed sterilization pouch containing<br>SCBI, CI and barrier material. | Sealed sterilization pouch containing<br>SCBI, CI and barrier material. | Same |
| Biological<br>Indicator | Celerity 20 HP Biological Indicator | Celerity 20 HP Biological Indicator | Same |
| Chemical<br>Indicator | VERIFY HPU Chemical Indicator | VERIFY HPU Chemical Indicator | Same |
| Means to<br>distinguish<br>processed pack<br>from unprocessed | Proposed device's internal indicator is<br>visible through the pack. | Proposed device's internal indicator is<br>visible through the pack. | Same |
| Required<br>accessories | CELERITY HP Incubator | CELERITY HP Incubator | Same |

### Table 5-1 Summary of nack Physical Description and Technological Pronerties

#### 6. Summarv of Nonclinical Tests

Performance testing to demonstrate substantial equivalence to the predicate has been completed and is summarized in Table 5-2 below.

{6}------------------------------------------------

# STERIS SPECIAL 510(k) PREMARKET NOTIFICATION CELERITY 20 HP Challenge Pack

| Test | Acceptance Criteria | Conclusion |
|---------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------|
| Simulated Use | Demonstrate the pack shows passing results in worst-case<br>load under worst-case sterilization conditions (Fast Non<br>Lumen Cycle of V-PRO maX 2 Sterilizer) | PASS<br>All CI complete change<br>All BI inactivated |

#### Tahle 5-2 Sr clinical Testi f N

### 7. Conclusion

The conclusion drawn from the non-clinical performance test demonstrate that the subject device is as safe, as effective and performs as well as or better than the legally marketed predicate device, K173488, Class II (21 CFR 880.2800, Product code FRC).